ALLO vs TM · rev $22.0K vs P/E 9.7, rev $234.60B
Allogene Therapeutics Inc (ALLO) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
ALLO currently screens at market cap $258.1M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the ALLO and TM stock pages for the full models.
Not investment advice.